Bevacizumab Intravenous and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Bevacizumab Intravenous and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Insulin Glargine (U-100) Vials
- Bevacizumab Intravenous-Insulin Glargine (U-300) Pens
- Bevacizumab Intravenous-Insulin glargine and lixisenatide
- Bevacizumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Bevacizumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Bevacizumab Intravenous-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bevacizumab-awwb
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bevacizumab-awwb Intravenous
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bevespi Aerosphere
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bevyxxa
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bexarotene
- Insulin Glargine (U-100) Cartridge Systems and Pens-Bexarotene (Systemic)